menu search

vTv Therapeutics Announces 2022 Third Quarter Financial Results and Provides Corporate Update

vTv Therapeutics Announces 2022 Third Quarter Financial Results and Provides Corporate Update
Company on-track to initiate Phase 3 clinical trials of TTP399 in the first quarter of 2023 Industry veteran Paul Sekhri joins the Company as President, Chief Executive Officer, and member of the Board of Directors Agreements with CinRx Pharma and a subsidiary to provide additional capital and access to CinRx’s industry and clinical trial expertise […] The post vTv Therapeutics Announces 2022 Third Quarter Financial Results and Provides Corporate Update appeared first on ForexTV... Read More
Posted: Nov 10 2022, 22:25
Author Name: forextv
Views: 110872

Search within

Pages Search Results: